GEMINI

A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects with ACS

Stadium
klaar
Middel
rivaroxaban
Populatie
ASCVD
Fase
II
First Patient In
15 mei 2015
Last Patient In
23 februari 2016
Last Patient Last Visit
23 augustus 2016

National Lead

prof. dr. J.H. Cornel

Cardioloog

Studiedirecteur

dr. M.W.J. van Hessen

Cardioloog

De pagina is verlopen.